U.S. Semiconductors Stock News

What recent performance says about Pitney Bowes (PBI) Pitney Bowes (PBI) has drawn investor attention after a period where the stock showed mixed short term moves, including a 1 day decline of 0.7% and gains over the past week and year. See our latest analysis for Pitney Bowes. The recent 6.7% 7 day share price return, alongside a 5.2% year to date share price gain and a 214% three year total shareholder return, points to momentum that has been building rather than fading. If Pitney Bowes has...

REX American Resources reported past fourth-quarter 2025 sales of US$157.96 million, with net income rising to US$43.75 million, and full-year 2025 sales of US$650.49 million alongside net income of US$82.95 million. Record earnings per share, record ethanol sales volumes, substantial US$28.00 million in 45Z tax credits, and progress on capacity expansion and carbon capture projects collectively reshaped the company’s earnings mix and growth profile. We’ll now examine how record 2025...

What stands out about Welltower right now Welltower (WELL) sits at the center of what it calls the silver economy, with a portfolio of more than 2,000 seniors and wellness housing communities across the United States, United Kingdom and Canada. At a recent share price of US$195.77 and a market value of about US$136.6b, the company reports annual revenue of US$10.84b and net income of US$936.85m, primarily from seniors housing operating assets. See our latest analysis for Welltower. Recent...

Labor rally puts Neogen (NEOG) workforce issues in focus Warehouse workers at Neogen (NEOG) in Lansing, Michigan, represented by Teamsters Local 243, are planning a March 27 rally over alleged unfair labor practices, seeking improved pay, workplace respect, and stronger representation. This organizing effort draws attention to potential labor related risks for Neogen, including the possibility of higher wage costs or short term operational friction. Some investors may weigh these...

Framing Solventum after recent share price moves Solventum (SOLV) has come under pressure recently, with the share price weaker over the past week, month, and past 3 months. This has prompted investors to reassess how the healthcare group’s fundamentals line up with current market pricing. See our latest analysis for Solventum. At a current share price of US$62.76, Solventum’s recent 1 month share price return of 15.42% and year to date share price return of 20.58% suggest momentum has been...

We'd be surprised if Datavault AI Inc. ( NASDAQ:DVLT ) shareholders haven't noticed that the Chairman & CFO, Brett...

Today is shaping up negative for LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders, with the analysts delivering a...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Tron ( NASDAQ:TRON...

We wouldn't blame TMC the metals company Inc. ( NASDAQ:TMC ) shareholders if they were a little worried about the fact...

Middleby has appointed Brittany Cerwin as its new Chief Financial Officer to lead the finance function during a major portfolio transformation. Outgoing CFO Bryan Mittelman will transition to a Special Advisor role and focus on the planned spin off of Middleby’s Food Processing business. The leadership change comes as Middleby prepares to position itself as a more focused commercial foodservice company. For investors watching NasdaqGS:MIDD, this leadership shift lands after a challenging...

If you are wondering whether J. M. Smucker is starting to look attractively priced or still has room to fall, the recent share moves invite a closer look at what you are really paying for. The stock last closed at US$95.24, with returns of 4.2% decline over 7 days, 17.9% decline over 30 days, 1.4% decline year to date, 14.8% decline over 1 year, 32.4% decline over 3 years, and 10.8% decline over 5 years. Recent coverage has focused on how sentiment around packaged foods companies is...

Earlier this month, National Health Investors, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, and announced a US$500 million at-the-market follow-on common equity offering structured through an income trust. This combination of a sizable equity program and broad shelf capacity increases the REIT’s funding options and may influence how it balances growth investments with potential dilution and balance sheet...

Insider selling raises questions around Agnico Eagle Mines (AEM) Recent filings show heavy insider selling at Agnico Eagle Mines (AEM), including US$16m of disposals over the past quarter and an US$8m sale by the CEO, with no offsetting insider purchases reported. See our latest analysis for Agnico Eagle Mines. Against this insider activity, Agnico Eagle Mines’ recent share price moves have been mixed, with a 7.97% 7 day share price return and a 23.13% 30 day share price decline. However, a...

BlackLine (BL) has just expanded its share repurchase authorization by US$100 million to US$500 million and added two directors, moves that frame how management is thinking about capital allocation and future execution. See our latest analysis for BlackLine. BlackLine’s share price has been under pressure, with a 1-day share price return showing a 4.02% decline and a 7-day share price return showing a 7.82% decline. The 1-year total shareholder return shows a 26.14% decline, indicating that...

Why JPMorgan’s upgrade is drawing attention to Air Products and Chemicals (APD) JPMorgan’s recent upgrade of Air Products and Chemicals (APD), tied to stable earnings and helium market support, has pushed the stock onto more investors’ radars, particularly among those monitoring industrial gases and energy related demand. See our latest analysis for Air Products and Chemicals. The recent upgrade comes after a period of building momentum, with a 90 day share price return of 17.89% and a year...

Best Buy stock performance snapshot Best Buy (BBY) has seen mixed share performance, with the price down about 9% year to date and 8% over the past year, while the past month shows a modest positive return. See our latest analysis for Best Buy. The recent 1 month share price return of 1.63% contrasts with a weaker 3 month share price return of a 7.16% decline and a 1 year total shareholder return of an 8.17% decline, suggesting momentum has been fading rather than building. If you are...

Some Universal Insurance Holdings, Inc. ( NYSE:UVE ) shareholders may be a little concerned to see that the Executive...

NRx Pharmaceuticals, Inc. ( NASDAQ:NRXP ) is possibly approaching a major achievement in its business, so we would like...

A shareholder proposal seeks to cap executive severance at Capital One Financial (NYSE:COF) at 2.99 times base salary plus target bonus. The proposal would require shareholder approval for any senior manager pay package that exceeds this threshold. Capital One has filed a definitive proxy statement recommending that shareholders vote against the proposal at its May annual meeting. Capital One Financial, the parent of Capital One Bank, operates across credit cards, consumer lending, and...

Wondering whether Curtiss-Wright at around US$663 per share still offers value, or if most of the opportunity has already been priced in. The stock has recorded a 1 year return of 109.8% and a 3 year return of 279.6%. In contrast, the 7 day and 30 day returns of a 1.1% decline and a 5.3% decline hint at some recent cooling after a strong run. Over 5 years, Curtiss-Wright has delivered a very large total return of 463.7%. This naturally raises questions about what is now embedded in the...

If you are trying to figure out whether CRISPR Therapeutics is attractively priced or not, the recent share performance gives you a lot to think about. The stock last closed at US$45.75, with a 1.1% decline over 7 days, a 23.9% decline over 30 days, a 14.9% decline year to date, but a 23.7% gain over 1 year and a 1.1% gain over 3 years compared to a 61.7% decline over 5 years. These shifts in returns have kept CRISPR Therapeutics on many watchlists, as investors weigh shorter term weakness...

In March 2026, global talent solutions and consulting firm Robert Half was named by Fortune as one of America's Most Innovative Companies, highlighting its AI-powered tools and proprietary data-driven capabilities in improving talent matching and client support. This innovation recognition comes as Robert Half continues to contend with declining sales and earnings, underscoring a tension between its technology progress and current business headwinds. Now we will examine how this innovation...

If you are wondering whether Greif is offering fair value at its recent price, this breakdown will help you see how the current share level stacks up against several valuation checks. The stock recently closed at US$66.37, with a 6.0% return over the past 7 days, an 8.7% decline over 30 days, a 3.0% decline year to date, and a 25.2% gain over the past year, which may influence how you think about both upside potential and risk. Those swings sit alongside a longer track record, with returns...

Recent price action and business context Legence (LGN) has drawn fresh attention after a recent share price move, with the stock closing at US$54.75 and showing mixed short term returns over the past week, month and past 3 months. For readers tracking the underlying business, Legence reports US$2.55b in revenue across engineering, installation and maintenance services for mission critical building systems in the United States. These operations are supported by two segments: Engineering &...